The Inter-Agency Task Force for the Management of Emerging Infectious Diseases has approved the collaboration with five coronavirus disease 2019 (Covid-19) vaccine manufacturers from China and Taiwan to be used in clinical trials in the country.

The manufacturers are Chinese Academy of Science-Guangzhou Institute of Biomedicine and Health, Sinopharm-Wuhan Institute and Beijing Biologicals Institute and Sinovac Biotech Ltd. of China, and Adimmune Corp. and Academia Sinica of Taiwan.